ORCID as entered in ROS

Select Publications
2025, 'Endometriosis is not the endometrium: Reviewing the over-representation of eutopic endometrium in endometriosis research.', Elife, 14, http://dx.doi.org/10.7554/eLife.103825
,2025, 'The antibody–drug conjugate targeting ROR1, NBE-002, is active in high-grade serous ovarian cancer preclinical models', Therapeutic Advances in Medical Oncology, 17, http://dx.doi.org/10.1177/17588359251332471
,2025, 'The Multi-Kinase Inhibitor GZD824 (Olverembatinib) Shows Pre-Clinical Efficacy in Endometrial Cancer', Cancer Medicine, 14, http://dx.doi.org/10.1002/cam4.70531
,2024, 'Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer', Molecular Therapy Oncology, 32, http://dx.doi.org/10.1016/j.omton.2024.200911
,2024, 'Author Correction: A comparative analysis of 2D and 3D experimental data for the identification of the parameters of computational models (Scientific Reports, (2023), 13, 1, (15769), 10.1038/s41598-023-42486-3)', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-023-50403-x
,2024, 'Accurate Identification of Cancer Cells in Complex Pre-Clinical Models Using a Deep-Learning Neural Network: A Transfection-Free Approach', Advanced Biology, 8, http://dx.doi.org/10.1002/adbi.202400034
,2024, 'Accurate Identification of Cancer Cells in Complex Pre‐Clinical Models Using a Deep‐Learning Neural Network: A Transfection‐Free Approach (Adv. Biology 11/2024)', Advanced Biology, 8, http://dx.doi.org/10.1002/adbi.202470112
,2023, 'A comparative analysis of 2D and 3D experimental data for the identification of the parameters of computational models', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-42486-3
,2023, 'Mixed large cell neuroendocrine carcinoma and high grade serous carcinoma of the ovary: a histopathological case report', Pathology, 55, pp. S55 - S55, http://dx.doi.org/10.1016/j.pathol.2022.12.178
,2022, 'Author Correction: ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target (Scientific Reports, (2020), 10, 1, (13906), 10.1038/s41598-020-70924-z)', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-15043-7
,2022, 'The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells', Pharmaceutics, 14, http://dx.doi.org/10.3390/pharmaceutics14040837
,2021, 'ROR1 and ROR2 expression in pancreatic cancer', BMC Cancer, 21, http://dx.doi.org/10.1186/s12885-021-08952-9
,2021, 'An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticles', Journal of Materials Chemistry B, 9, pp. 9123 - 9135, http://dx.doi.org/10.1039/d1tb01837j
,2021, 'Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer', Gynecologic Oncology, 162, pp. 720 - 727, http://dx.doi.org/10.1016/j.ygyno.2021.06.028
,2021, 'Ror2 is epigenetically regulated in endometrial cancer', Cancers, 13, pp. 1 - 16, http://dx.doi.org/10.3390/cancers13030383
,2020, 'ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target', Scientific Reports, 10, http://dx.doi.org/10.1038/s41598-020-70924-z
,2019, 'A low-fat diet up-regulates expression of fatty acid taste receptor gene FFAR4 in fungiform papillae in humans: a co-twin randomised controlled trial', British Journal of Nutrition, 122, pp. 1212 - 1220, http://dx.doi.org/10.1017/S0007114519002368
,2018, 'Expression of the candidate fat taste receptors in human fungiform papillae and the association with fat taste function', British Journal of Nutrition, 120, pp. 64 - 73, http://dx.doi.org/10.1017/S0007114518001265
,2016, 'Mechanism of fat taste perception: Association with diet and obesity', Progress in Lipid Research, 63, pp. 41 - 49, http://dx.doi.org/10.1016/j.plipres.2016.03.002
,2016, 'A comparison of collection techniques for gene expression analysis of human oral taste tissue', Plos One, 11, http://dx.doi.org/10.1371/journal.pone.0152157
,